America Finally Crushed Smoking—Then a New Budget Shift
U.S. adults now smoke at a record low, but a shift in public-health funding threatens the playbook that drove the dec...
When Financial Circumstances Change
Life changes can disrupt budgets. Learn to reforecast income, trim discretionary spending, and adjust savings goals to stay financially secure.
18,560 articles
Portfolios Shift Toward Bitcoin as GOP Signals Rise
A new study finds Republican lawmakers are increasingly tilting their portfolios toward Bitcoin and related crypto as...
Uncle Buying Into Quantum: Should You Invest Today?
When the government pours billions into quantum research, a surge in quantum stocks often follows. This guide breaks ...
Life360 (LIF) 2026 Earnings Outlook: Key Trends to Watch
Life360 faces a pivotal year in 2026. This guide breaks down what the Q1 results could reveal about growth, margins, ...
AI Is Turning Workers Into Superhumans, Leaders Lag
AI is accelerating frontline work even as executive teams struggle to adapt. Leaders must redesign decision-making to...
Trump Appointed Real-Estate Heir Sparks Market Debate
The White House has tapped a real-estate heir as acting director of national intelligence, a move that drew sharp que...
Take-Two's Path Profitability Coming: November Strategy
November looms as a potential turning point for Take-Two. This article breaks down how the company could turn a block...
Social Security Faces 2032 Looming Cliff for Retirees
A major fiscal analysis warns that Social Security could suffer a 24% across-the-board cut by 2032, costing about $50...
Fed May Be Already Late Hiking Interest, Markets React
Friday's strong jobs data complicates the Fed's rate path, signaling higher borrowing costs ahead while raising quest...
Which Better Artificial Intelligence ETFs: CHAT and XLK
AI investing can take two paths: a targeted, actively managed approach with CHAT or a broad, low-cost tech track with...
After Shares Surged Month: Micron CEO Sells $38M Stock
Micron’s stock surged dramatically, then the CEO sold a large block of shares. Is this a warning sign or a routine ad...
Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status